Obinutuzumab in the treatment of idiopathic refractory membranous nephropathy: an observational case series
ObjectiveIdiopathic refractory membranous nephropathy (IRMN) is a subset of nephrotic syndrome with a high risk of progression to end-stage renal disease, yet treatment options remain limited. Obinutuzumab, a humanized type II anti-CD20 antibody, induces efficient CD20+ cell depletion, leading to fa...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-02-01
|
| Serie: | Frontiers in Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1704970/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|